Abstracts Archive - Page 2435 of 2607 - ACR Meeting Abstracts

Abstract Number: 2529 • 2012 ACR/ARHP Annual Meeting
Molecular Mechanism of IgG4 Class Switch Recombination in IgG4-Related Disease
Hiroto Tsuboi¹, Mana Iizuka¹, Hiromitsu Asashima¹, Sayaka Tsuzuki¹, Yuya Kondo¹, Akihiko Tanaka², Masafumi Moriyama², Isao Matsumoto¹, Seiji Nakamura² and Takayuki Sumida¹, ¹Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, ²Faculty of Dental Science, Kyushu University, Fukuoka, Japan
Background/Purpose: IgG4-related disease (IgG4-RD) is a new disease entity characterized by high serum IgG4 levels, IgG4-positive plasmacytic infiltration and fibrosis in various organs. Although the…
Abstract Number: 2530 • 2012 ACR/ARHP Annual Meeting
Anti-Ribosomal P Antibodies in a Large Cohort of Autoimmune Hepatitis with No Evidence of Lupus: A Common Underlying Mechanism Targeting Liver?
Ana Luisa Calich¹, Vilma S. T. Viana¹, Eduardo L. Cançado², Débora R. Terrabuio², Francisco Tustumi¹, Elaine P. Leon¹, Clovis Artur Silva³, Eduardo F. Borba Neto¹ and Eloisa Bonfa¹, ¹Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ²Gastroenterology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ³Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy
Background/Purpose: Anti-ribosomal P proteins antibody (anti-rib P) is a highly specific marker for systemic lupus erythematosus (SLE) and it is associated with liver involvement in…
Abstract Number: 2531 • 2012 ACR/ARHP Annual Meeting
The Relapsing Polychondritis Disease Activity Index: International Development and Initial Validation of the First Disease Activity Score for Relapsing Polychondritis
Laurent Arnaud¹, Hervé Devilliers², Stanford L. Peng³, Zahir Amoura⁴ and the RPDAI study group⁵, ¹Internal Medicine, Assistance Publique-Hôpitaux de Paris, Hopital Pitié-Salpétrière, Paris, France, ²Internal medicine, CHU Dijon, Dijon, France, ³Department of Rheumatology, Virginia Mason Medical Center, Seattle, WA, ⁴Department of Internal Medicine 2. Referal center for SLE/APS, CHU Pitié-Salpêtrière, Paris, France, ⁵Assistance Publique-Hôpitaux de Paris, Hopital Pitié-Salpétrière, Paris, France, Paris
Background/Purpose: Relapsing polychondritis (RP) is a rare multi-systemic disorder characterized by recurrent, destructive, inflammatory lesions of the auricular, nasal, and laryngo-tracheo-bronchial cartilages. Additional clinical features…
Abstract Number: 2532 • 2012 ACR/ARHP Annual Meeting
Whole Transcriptome Analysis in Relapsing Polychondritis: A Single-Center Analysis of 35 Patients
Laurent Arnaud¹, Alexis Mathian², Bruno Faivre³, Karim Dorgham³, Julien Haroche², Nathalie Costedoat-Chalumeau¹, Jean-Charles Piette², Guy Gorochov⁴ and Zahir Amoura¹, ¹Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP & UPMC Univ Paris 06, Paris, France, ²Department of Internal Medicine 2. Referal center for SLE/APS, Hôpital Pitié-Salpêtrière, AP-HP & UPMC Univ Paris 06, Paris, France, ³Institut National de la Santé et de la Recherche Médicale, INSERM UMR-S 945, Paris, France, ⁴Inserm UMRS945, Institut National de la Santé et de la Recherche Médicale, INSERM UMR-S 945, Paris, France
Background/Purpose: Relapsing polychondritis (RP) is a severe and episodic inflammatory condition involving cartilaginous structures, predominantly those of the ears, nose, and laryngotracheobronchial tree. Other affected…
Abstract Number: 2533 • 2012 ACR/ARHP Annual Meeting
Weight Loss Is Associated with Structure Modification in Subjects with Radiographic Osteoarthritis of the Knee: Data From the Osteoarthritis Initiative
Marc C. Hochberg¹, Danuta I. Bujak², Jeffrey W. Duryea³, Knachelle Favors⁴ and John D. Sorkin⁴, ¹Department of Medicine, University of Maryland, Baltimore, MD, ²School of Medicine, University of Maryland, Baltimore, MD, ³Dept of Radiology, Brigham & Women, Boston, MA, ⁴VA Maryland Health Care System, Baltimore, MD
Background/Purpose: Obesity is a risk factor for the development and progression of knee osteoarthritis (OA) and weight loss is recommended as part of the management…
Abstract Number: 2534 • 2012 ACR/ARHP Annual Meeting
The Intensive Diet and Exercise for Arthritis Trial (IDEA): 18-Month Radiographic and MRI Outcomes
David J. Hunter¹, D. Beavers², Felix Eckstein³, Ali Guermazi⁴, Richard F. Loeser⁵, Barbara J. Nicklas⁶, Shannon Mihalko⁷, Gary D. Miller⁷, Mary Lyles⁸, Paul DeVita⁹, Claudine Legault¹⁰, J. Jeffery Carr¹¹, Jeff D. Williamson⁸ and Stephen P. Messier⁷, ¹Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, ²Wake Forest University, Winston Salem, NC, ³Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria, ⁴Radiology, Boston University, Boston, MA, ⁵Section Of Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, ⁶Center on Aging, Wake Forest University School of Medicine, Winston-Salem, NC, ⁷Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC, ⁸Center on Aging, Wake Forest University School of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, ⁹Department of Exercise and Sport Science, East Carolina University, Greenville, NC, ¹⁰Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, ¹¹Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC
Background/Purpose: Dietary induced weight loss is a proven non-pharmacologic intervention for osteoarthritis. Based upon current literature it is unclear if weight loss modifies structural progression.…
Abstract Number: 2535 • 2012 ACR/ARHP Annual Meeting
Childhood Physical Fitness Predicts Adulthood Knee Cartilage Volume and Bone Area: A 25-Year Cohort Study
Benny Samuel Eathakkattu Antony¹, Graeme Jones¹, Alison Venn², Leigh Blizzard³, Flavia Cicuttini⁴, Lyn March⁵, Terry Dwyer⁶ and Changhai Ding⁷, ¹Musculoskeletal, Menzies Research Institute Tasmania, Hobart, Australia, ²Epidemiology, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, ³Biostatistics, Hobart, Australia, ⁴Epidemiology and Preventive Medicine, Monash University, Central and Eastern Clinical School, Melbourne, Australia, ⁵University of Sydney, Institute of Bone and Joint Research, Royal North Shore Hospital, St Leonards - Sydney, Australia, ⁶Director, Murdoch Children's Research Institute, Melbourne, Australia, ⁷Musculoskeletal and Epidemilogy, Menzies research institute & Monash University, Hobart, Australia
Background/Purpose: Physical activity interventions are often advised for management of osteoarthritis patients, despite contradictory findings regarding its effect on knee structure. In particular, there is…
Abstract Number: 2536 • 2012 ACR/ARHP Annual Meeting
The Effects of Intensive Diet and Exercise On Bone Density in Older Adults with Knee Osteoarthritis: The Intensive Diet and Exercise for Arthritis (IDEA) Trial
Nicole R. Walton¹, Richard F. Loeser², Daniel Beavers³, Barbara J. Nicklas⁴, Mary Lyles⁵ and Stephen P. Messier⁶, ¹Rheumatology, Wake Forest University School of Medicine, Winston Salem, NC, ²Section Of Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, ³Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, ⁴Center on Aging, Wake Forest University School of Medicine, Winston-Salem, NC, ⁵Center on Aging, Wake Forest University School of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, ⁶Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC
Background/Purpose: Previous studies on the effects of weight loss and exercise on bone mass show conflicting results and there are no studies of older adults…
Abstract Number: 2537 • 2012 ACR/ARHP Annual Meeting
Cross-Sectional and Longitudinal Associations Between Circulating Leptin and Knee Cartilage Thickness in Older Adults
Oliver Stannus¹, Yuelong Cao², Benny Samuel Eathakkattu Antony¹, Graeme Jones³ and Changhai Ding⁴, ¹Musculoskeletal, Menzies Research Institute Tasmania, Hobart, Australia, ²Musculoskeletal, Orthopaedics, Menzies Research Institute Tasmania, Research Institute of Orthopaedics, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,, Hobart, Australia, ³Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, ⁴Musculoskeletal and Epidemilogy, Menzies research institute & Monash University, Hobart, Australia
Background/Purpose: To investigate cross-sectional and longitudinal associations between serum leptin levels and knee cartilage thickness in older adults. Methods: A prospective cohort of 163 randomly…
Abstract Number: 2538 • 2012 ACR/ARHP Annual Meeting
The Association of Fat Mass and Skeletal Muscle Mass with Clinical and Structural Knee Osteoarthritis: The Netherlands Epidemiology of Obesity Study
A. Willemien Visser¹, Marieke Loef¹, Martin den Heijer², Monique Reijnierse³, Frits R. Rosendaal² and Margreet Kloppenburg⁴, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands, ³Radiology, Leiden University Medical Center, Leiden, Netherlands, ⁴Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Body mass index (BMI) is an important risk factor for knee osteoarthritis (OA), but BMI depends only upon height and weight and gives no…
Abstract Number: 2539 • 2012 ACR/ARHP Annual Meeting
Fine-Specificity of Anti-Citrullinated Peptide Auto-Antibodies: Associations with Cardiac Structure and Function in Rheumatoid Arthritis
Laura Geraldino-Pardilla¹, Jon T. Giles², Jeremy Sokolove³, William H. Robinson⁴ and Joan M. Bathon⁵, ¹Division of Rheumatology, Columbia University, College of Physicians and Surgeons, New York, NY, ²Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, ³Medicine, VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, ⁴Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, ⁵Columbia University, New York, NY
Background/Purpose: Despite advancements in rheumatoid arthritis (RA) treatment, standardized mortality rates remain up to 3 times higher than in the general population. Cardiovascular disease (CVD)…
Abstract Number: 2540 • 2012 ACR/ARHP Annual Meeting
Prescription of Tumour Necrosis Factor α Antagonists Is Strongly Associated with a Reduction in Hospital Admissions and in Musculoskeletal Surgical Procedures for Rheumatoid Arthritis Based On a 16 Year Analysis of Nationwide Data
Leonard C. Harty¹, Gary O'Toole², Kathleen Bennett³ and Oliver M. FitzGerald⁴, ¹Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland, ²Department of Orthopaedic Surgery, St. Vincent's University Hospital, Dublin, Ireland, ³Trinity Centre for Health Sciences, Department of Pharmacology & Therapeutics, Dublin, Ireland, ⁴Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland
Background/Purpose: Comorbidities, joint destruction leading to orthopaedic intervention and physical disability are predictable outcomes of uncontrolled Rheumatoid Arthritis (RA). Synthetic DMARDS have a slow mechanism…
Abstract Number: 2541 • 2012 ACR/ARHP Annual Meeting
High Risk of Intensive Care Unit Admission in Rheumatoid Arthritis Patients: A Population Based Study
Christine Peschken¹, Carol A. Hitchon², Allan Garland³, Charles N. Bernstein³, Randy Fransoo⁴ and Ruth Ann Marrie³, ¹Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, ²University of Manitoba, Winnipeg, MB, Canada, ³Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, ⁴Manitoba Centre for Health Policy, University of Manitoba, Winnipeg, MB, Canada
Background/Purpose: Comorbidity in Rheumatoid arthritis (RA) has been a focus of intensive research in recent years, but little is known about the incidence of critical…
Abstract Number: 2542 • 2012 ACR/ARHP Annual Meeting
The Association Between Inflammatory Markers and Hyperlipidemia and the Risk of Myocardial Infarction in Patients with Rheumatoid Arthritis
Jie Zhang¹, Lang Chen², Elizabeth S. Delzell³, Paul M. Muntner³, William B. Hillegass⁴, Monika M. Safford⁵, Iris E. Navarro² and Jeffrey R. Curtis⁶, ¹Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ⁴Preventative Medicine, Birmingham, AL, ⁵Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, ⁶Rheumatology & Immunology, Univ of Alabama-Birmingham, Birmingham, AL
Title: The Association between Inflammatory Markers and Hyperlipidemia and the Risk of Myocardial Infarction in Patients with Rheumatoid Arthritis Background/Purpose: Patients with rheumatoid arthritis (RA)…
Abstract Number: 2543 • 2012 ACR/ARHP Annual Meeting
Hospitalized Bacterial Infections Among U.S. Veterans with Rheumatoid Arthritis Initiating TNF Antagonist and Newer Biologic Agents
Jeffrey R. Curtis¹, Shuo Yang², Nivedita M. Patkar³, Lang Chen⁴, Jasvinder A. Singh⁵, Grant W. Cannon⁶, Ted R. Mikuls⁷, Elizabeth S. Delzell⁸, Kenneth G. Saag⁹, Monika M. Safford¹⁰, Scott DuVall¹¹, Kimberly Alexander¹², Pavel Napalkov¹², Aaron Kamauu¹³ and John Baddley¹⁴, ¹Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³Immunology/Rheumatology, Univ of Alabama-Birmingham, Birmingham, AL, ⁴Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁵Department of Medicine, University of Alabama, Tuscaloosa, AL, ⁶Division of Rheumatology, George E. Wahlen VA Medical Center, Salt Lake City, UT, ⁷Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, ⁸Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ⁹Div Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, ¹⁰Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, ¹¹VA Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ¹²Epidemiology, Genentech, Inc., South San Francisco, CA, ¹³Anolinx, Bountiful, UT, ¹⁴Medicine, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Risks of hospitalized infections for newer biologic agents have not been well characterized compared to risks for anti-TNF therapy. Purpose: To compare the risk…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].